Useful Advices
#1 in Business Subscribe Email Print

You are here: Home > Business > Ethics > Experts Who Do Not Stay Up on the Latest in the Field

Tags

  • cycle
  • there
  • increase
  • biological product
  • biological product
  • biological product

  • Links

  • How to Work With a Ghostwriter
  • Tips For Buying Home Exercise Equipment
  • A New Solution To Ordering Takeaways!
  • Useful Advices - Experts Who Do Not Stay Up on the Latest in the Field

    When reading Trade Journals it becomes quite obvious of the problems
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    with many of the articles. They appear to be news worthy articles,
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ut are simply trying to bend the mind of the reader over to their vi
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    w of the industry in order to sell them something. Of course for the
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    Trade Journal it works because it is free filler articles and means
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ess cost in paying writers. It also gives the chance that the author
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    of the articles or series of articles may advertise in the Trade Jou
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    nal in the future.

    This is such common practice in trade journals t
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    at no one ever calls it into question in public, but privately they
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    o think about this problematic situation. There is something that is
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    worse than an industry professional writing such articles and that i
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    s a former expert in the field who has been away for 20-years from t
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    e industry commenting on the current direction of the Industry.

    It
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    s like a PhD in a technology, which is 20-years old commenting on th
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    current trends. Many are concerned about these things and one recen
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    think tanker (me) commented on this and challenged a former PhD Ind
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    stry professional on a future trend. The so-called former industry e
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    pert gentleman would not yield his view, yet today we see he was wro
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    g, dead wrong on his assumptions. This should be too surprising, as
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    hings change; it is the only constant in fact. Think on this in 2006


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.usefuladvices.org.ua/article/18975/usefuladvices-Experts-Who-Do-Not-Stay-Up-on-the-Latest-in-the-Field.html">Experts Who Do Not Stay Up on the Latest in the Field</a>

    BB link (for phorums):
    [url=http://www.usefuladvices.org.ua/article/18975/usefuladvices-Experts-Who-Do-Not-Stay-Up-on-the-Latest-in-the-Field.html]Experts Who Do Not Stay Up on the Latest in the Field[/url]

    Related Articles:

    Limited Liability Corporation Advantages

    Franchise Disclosure Law and The Right To Privacy

    Improve Your Staffing Agencies Brand Identity

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com